John M. Centanni

Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.

MCC Holdings, Inc. manufactures and sells industrial valves. The company was registered in September 3, 1987 and is headquartered in Stamford, CT.

F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

Cobalt Group, Inc. provides web-based marketing services. The company was founded in 1995 and is headquartered in Seattle, WA.

W.L. Ross & Co. LLC (WL Ross & Co) is a private equity subsidiary of Invesco Ltd. founded in 2000 by Wilbur Louis Ross. The firm is headquartered in New York.

CompassCare, Inc. provides healthcare information technology services. The company provides practice management system that includes an EMR that delivers invoices faster, reduces payment cycles, and increases the efficiency of case management and claim adjudication. It was founded in 2001 and is headquartered in Bannockburn, IL

Aisling Capital LLC (Aisling Capital) is an venture capital firm founded in 1999 by Dennis Joseph Purcell. The firm is headquartered in New York, New York.

Cempra Pharmaceuticals, Inc. develops medicines for treating drug-resistant bacterial infections. The firm's antibacterial products, both in clinical trials, address the urgent and increasing need for new treatments targeting drug-resistant bacterial infections in both the hospital and the community. The company was founded by Prabhavathi B. Fernandes IN 2006 and is headquartered in Chapel Hill, NC.

Topaz Pharmaceuticals, Inc. operates as a pharmaceutical company which focuses on developing and commercializing treatments for the pediatric and dermatology markets. Its lead investigational product is a topical cream formulation of ivermectin which is under development. The firm provides medicines for the treatment of head lice, acne and infections, as well as vaccines against childhood diseases. The company was founded by Donald P. Beeman and Nicholas U. Spring in 2005 and is headquartered in Horsham, PA.

DisperSol Technologies LLC offers plastics processing technology to pharmaceutical manufacturing companies. It offers KinetiSol, a pharmaceutical processing technology that provides solutions to oral drug delivery problems and for amorphous solid dispersion systems; and ArmoRx Platform, a processing technology that enables use of certain compendial pharmaceutical polymers to produce oral dosage forms that are inherently abuse deterrent. The company was founded by Gershon Yaniv in 2007 and is headquartered in Georgetown, TX.

HealthCare Ventures LLC (HealthCare Ventures) is a venture capital firm founded in 1985 by Harold R. Werner. The firm is headquartered in Cambridge, Massachusetts.

California Institute of Technology provides education focusing on science, engineering, academia, business, and public service. The company was founded in 1891 and it is headquartered in Pasadena, CA.

Bayer Pharma AG engages in the development and production of prescription drugs for the treatment of cardiovascular diseases and women's illnesses, as well as special therapy in the areas of oncology, hematology, and ophthalmology. It also offers medical equipment used in diagnostic imaging with applications in the field of radiology. The company was founded on March 9, 1965 and is headquartered in Berlin, Germany.

ADMA Plasma Biologics, Inc. develops medicines for the treatment of infectious diseases. The company was founded in 2007 and is headquartered in Hackensack, NJ.

Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland.

Roche NimbleGen, Inc. provides products and services to the life science research market. The private company is based in Madison, WI. Frank Pitzer has been the CEO of the company since 2010.

Exicure Operating Co. operates as a biopharmaceutical company commercializing spherical nucleic acid constructs as gene regulation and modulation agents for diseases including applications in oncology, dermatology, neurology, and for immune disorders. The SNA constructs allow the use of oligonucleotide-based therapies to treat diseases in a range of tissue types. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in 2011 and is headquartered in Skokie, IL.

Part of RCMA Services (UK) Ltd., RCMC Capital LLP is a private limited partnership based in London, UK. RCMC Capital is authorised and regulated by the FCA as an alternative investment fund manager and is also registered with the Commodities and Futures Trading Commission as a commodity pool operator. The British company provides general information about their services on their website, but it is not intended for public use or distribution. Investors should independently verify and check the accuracy, completeness, reliability, and suitability of the information before making any investment decision. The information contained on the webpage does not constitute financial, investment, legal, accounting, tax, or other professional advice or a solicitation for investment in RCMA's funds. The company was founded in 2004 and Douglas King has been the CEO of the company since 2004.

Indapta Therapeutics, Inc. operates as a biotechnology company. It focuses on developing and commercializing a proprietary, first-in-class, off-the-shelf allogeneic cell therapy to treat multiple types of difficult-to-treat hematologic cancers and solid tumors. The company was founded by Guy DiPierro, Ronald A. Martell, Sungjin Kim and John Sunwoo in 2017 and is headquartered in Houston, TX.

Reunion Neuroscience, Inc. operates drug discovery and development business. Its novel psychedelic drug development, committed to innovating therapeutic solutions for mental health conditions by developing proprietary serotonin receptor agonist compounds. The company was founded on October 1, 2020 and is headquartered in Toronto, Canada.